Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation
Phase 1
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2012-02-01
- Last Posted Date
- 2012-02-01
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 800
- Registration Number
- NCT01523236
Donepezil 10 mg Tablets Under Fasting Conditions
- First Posted Date
- 2011-09-23
- Last Posted Date
- 2011-09-23
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT01439230
- Locations
- 🇨🇦
Anapharm, Montreal, Quebec, Canada
Donepezil 10 mg Tablets Under Fed Conditions
- First Posted Date
- 2011-09-23
- Last Posted Date
- 2011-09-23
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 26
- Registration Number
- NCT01439243
- Locations
- 🇨🇦
Anapharm, Montreal, Quebec, Canada
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2011-05-30
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT01344369
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Bioequivalence
- Interventions
- Drug: Ovcon® 35 Fe
- First Posted Date
- 2011-04-22
- Last Posted Date
- 2011-05-25
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 36
- Registration Number
- NCT01340625
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2011-03-08
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT01282814
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2011-03-08
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 18
- Registration Number
- NCT01282801
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.
- First Posted Date
- 2010-12-15
- Last Posted Date
- 2011-02-21
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 26
- Registration Number
- NCT01260922
- Locations
- 🇺🇸
PRACS Institute, Ltd., East Grand Forks, Minnesota, United States
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions
- First Posted Date
- 2010-12-15
- Last Posted Date
- 2011-02-21
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT01260896
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions
- First Posted Date
- 2010-12-15
- Last Posted Date
- 2011-02-21
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 26
- Registration Number
- NCT01260948
- Locations
- 🇺🇸
PRACS Institute, Ltd., East Grand Forks, Minnesota, United States